학술논문
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
Document Type
Article
Author
Source
In Blood 17 March 2022 139(11):1684-1693
Subject
Language
ISSN
0006-4971